2019 Basic Science Presentations

MSS01 Less is More: Comparison of Partial v. Full REBOA in a Porcine Hemorrhagic Shock Model Dominic M Forte, Woo S Do, MD, Jessica B Weiss, MD, Rowan R Sheldon, MD, Matthew J Eckert, MD, Matthew J Martin; Madigan Army Medical Center

MSS02 Interim analysis of a prospective, randomized, double blind, placebo controlled, phase IIb trial of the TLPLDC vaccine to prevent recurrence in resected stage III or IV melanoma patients. Jessica L Campf1, John W Myers1, Guy T Clifton1, Diane F Hale1, Tommy A Brown1, Timothy J Vreeland2, Robert Hi Andtbacka3, Adam C Berger4, James W Jakub5, Jeffrey J Sussman6, Alicia M Terando7, Mark B Faries8; 1San Antonio Military Medical Center, 2University of Texas MD Anderson Cancer Center, 3Huntsman Cancer Institute, 4Thomas Jefferson University Kimmel Cancer Center, 5Mayo Clinic, 6University of Cincinnati Cancer Institute, 7The Ohio State University Cancer Center, 8The Angeles Clinic

MSS03 Linear Tensile Force Testing in Porcine Model validates use of Novel Mesh Suture Christopher J Scheiber, MD, Dearth Christopher, PhD, Alfred Pisano, Liacouras Peter, PhD, Jason Souza, MD; WRNMMC

MSS04 Effects of Vasopressin and Norepinephrine on Wound Healing of Vascular Smooth Muscle and Endothelium Kenneth J Bogenberger, MD, Dao H Ho, PhD; Tripler Army Medical Center

MSS05 Immunologic Efficacy of E39 & E39’ Vaccination in a Phase I/IIa Trial in Ovarian & Endometrial Cancer Patients Annelies T Hickerson, MD1, Tommy A Brown II1, Kaitlin M Peace1, John W Myers III1, Timothy J Vreeland2, Diane F Hale1, Doreen O Jackson1, Julia M Greene3, John S Berry IV4, Guy T Clifton1, Garth S Herbert1, George E Peoples5; 1Brooke Army Medical Center, San Antonio, TX, 2University of Texas MD Anderson Cancer Center, Houston, TX, 3Tripler Army Medical Center, Honolulu, HI, 4Womack Army Medical Center, Fort Bragg, NC, 5Cancer Vaccine Development Program, San Antonio, TX